doi:10.3969/j.issn.1673-8640.2024.09.016

Abstract

CLC Number:

R373.9

Figures/Tables 5

References 21

[1]	NGUYEN T, NOUGARET S, CASTILLO P, et al. Cervical cancer in the pregnant population[J]. Abdom Radiol(NY), 2023, 48(5):1679-1693.
[2]	HUANG J, YIN C, WANG J. Relationship between vaginal microecological changes and oncogene E6/E7 and high-risk human papillomavirus infection[J]. J Obstet Gynaecol, 2023, 43(1):2161349.
[3]	YE Y, LI M, YANG W, et al. Characteristics of high-risk HPV infection in women with vaginal intraepithelial neoplasia in Beijing,China[J]. J Med Virol, 2023, 95(12):e29267.
[4]	MUÑOZ-BELLO J O, CARRILLO-GARCÍA A, LIZANO M. Epidemiology and molecular biology of HPV variants in cervical cancer:the state of the art in Mexico[J]. Int J Mol Sci, 2022, 23(15):8566.
[5]	DU H, LUO H, WANG C, et al. The prevalence of HR-HPV infection based on self-sampling among women in China exhibited some unique epidemiologic features[J]. J Clin Epidemiol, 2021,139:319-329.
[6]	LI W, HE F, LIU P, et al. Uterine corpus invasion in cervical cancer:a multicenter retrospective case-control study[J]. Arch Gynecol Obstet, 2021, 303(3):777-785.
[7]	胡佐鸿, 赵春. NIFTP对甲状腺细胞学TBS报告系统(2017版)的影响[J]. 临床与实验病理学杂志, 2021, 37(9):1085-1089.
[8]	祁昔琴, 刘婷婷, 朱伦. 宫颈脱落细胞p16/Ki-67双染联合DNA定量分析在宫颈癌筛查中的临床价值[J]. 中国临床研究, 2022, 35(2):172-176.
[9]	REIS B S, NOGUEIRA C M, MENESES A F P, et al. Experiences of women with advanced cervical cancer before starting the treatment:systematic review of qualitative studies[J]. Int J Gynaecol Obstet, 2023, 161(1):8-16.
[10]	PAK T, SADOWSKI E A, PATEL-LIPPMANN K. MR imaging in cervical cancer:initial staging and treatment[J]. Radiol Clin North Am, 2023, 61(4):639-649.
[11]	KUSAKABE M, TAGUCHI A, SONE K, et al. Carcinogenesis and management of human papillomavirus-associated cervical cancer[J]. Int J Clin Oncol, 2023, 28(8):965-974. DOI PMID
[12]	LI T, CHEN S, LI X, et al. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening[J]. Virol J, 2023, 20(1):116. DOI PMID
[13]	ZHU X, LI X, ONG K, et al. Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears[J]. Nat Commun, 2021, 12(1):3541. DOI PMID
[14]	梁羽飞, 韦晓芳, 褚伯良, 等. 宫颈脱落细胞DNA定量分析对宫颈病变高危型HPV初筛阳性患者分流的价值[J]. 浙江医学, 2020, 42(2):154-156.
[15]	张爱凤, 贾丽华, 裴俊丽. 北京通州地区女性生殖道高危型HPV感染现状与宫颈病变关系的研究[J]. 中国妇产科临床杂志, 2020, 21(1):58-59.
[16]	胡志军, 朱娟娟, 潘晓龙, 等. 铜陵市2 815例女性高危型HPV感染状况及基因型分布特征[J]. 中国微生态学杂志, 2020, 32(3):322-324.
[17]	江琴, 吴钊, 唐倩, 等. 宫颈液基细胞学筛查阴性及高危型人乳头瘤病毒筛查阳性患者临床病理特征分析[J]. 现代肿瘤医学, 2022, 30(17):3191-3195.
[18]	SHI R, QI W, CAI J, et al. Independent risk factors for high-risk human papillomavirus infection among rural women in Shanxi Province,China:a population-based,case-control study[J]. Arch Gynecol Obstet, 2023, 308(2):551-559.
[19]	王卉, 雷英, 闫晶晶, 等. 重庆市万州区已婚女性HPV感染危险因素和预测模型构建及验证[J]. 中华医院感染学杂志, 2023, 33(2):238-242.
[20]	ZHAO D, ZHANG L, XIE F, et al. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1,CIN2/3,and invasive cervical cancer:a 4-year routine clinical experience after implementation of systematic training and quality control programs[J]. BMC Cancer, 2020, 20(1):810.
[21]	田澄, 王志强, 金玉兰. 宫颈细胞DNA定量分析用于筛查宫颈病变的临床价值[J]. 中国医刊, 2021, 56(3):281-284.

感染模式	感染例数/例	构成比/%
单一感染	182	68.68
二重感染	56	21.13
三重感染	10	3.77
四重感染	7	2.65
五重感染	6	2.26
六重及以上感染	4	1.51

感染模式	感染例数/例	构成比/%
单一感染	182	68.68
二重感染	56	21.13
三重感染	10	3.77
四重感染	7	2.65
五重感染	6	2.26
六重及以上感染	4	1.51

组别	例数/例	感染例数/例	感染率/%
<31岁组	235	75	31.91
31~40岁组	405	76	18.77^*
41~50岁组	319	65	20.06^*
51~60岁组	122	24	19.67^*
61~70岁组	112	23	20.54^*
>70岁组	7	2	28.57^*

组别	例数/例	感染例数/例	感染率/%
<31岁组	235	75	31.91
31~40岁组	405	76	18.77^*
41~50岁组	319	65	20.06^*
51~60岁组	122	24	19.67^*
61~70岁组	112	23	20.54^*
>70岁组	7	2	28.57^*

组织活检结果	例数	液基细胞学TBS			HPV-DNA定量分析			TBS+DNA双智能诊断系统
组织活检结果	例数	炎症	ASCUS	LSIL+	-	可疑	+	-	+
炎症	1 155	1 072	65	18	1 062	83	14	1 063	92
CINⅠ	30	10	16	4	4	4	22	3	27
CINⅡ	7	0	2	5	0	0	7	0	7
CINⅢ	5	0	2	3	0	0	5	0	5
宫颈癌	3	0	1	2	0	0	3	0	3
合计	1 200	1 082	86	32	1 066	86	48	1 066	134

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 21

Related Articles 15

Recommended Articles

Metrics

筛查方法	特异性	敏感性	阴性预测值	阳性预测值
液基细胞学TBS	92.81	77.78	99.08	29.66
HPV-DNA定量分析	91.95	91.11	99.63	30.60
TBS+DNA双智能诊断系统	92.03	93.33	99.72	31.34

[1]	YAN Jianghong, WANG Le, MA Lin, YANG Shuo, GUO Weiwei, ZHAO Mengchuan, LIU Zehao, ZHAI Xiaoying. Clinical characteristics of acute lymphoblastic leukemia children infected with Epstein-Barr virus [J]. Laboratory Medicine, 2024, 39(6): 583-586.
[2]	WANG Xuqin, LIN Qianru, FENG Wanqing, DONG Yuan, YU Xiaolei, LIU Changhe, NING Zhen, SHEN Xin, PAN Qichao, LIN Yi. Validation of HIV-1 integrase genotyping sequence assay [J]. Laboratory Medicine, 2024, 39(4): 369-375.
[3]	. [J]. Laboratory Medicine, 2024, 39(1): 71-74.
[4]	LU Xinli, LIU Yong, LI Yan, WANG Yingying, AN Ning, LIU Meng. Identification of near full-length genome structures of new HIV-1 recombinant strains [J]. Laboratory Medicine, 2023, 38(11): 1015-1019.
[5]	ZHANG Yaxu, CUI Yanwei, LIU Ziyan. Preliminary research for the determination of HPV E6/E7 mRNA by nucleic acid molecular hybridization-flow cytometry [J]. Laboratory Medicine, 2023, 38(1): 46-50.
[6]	LIU Hongqian, SONG Chaohui, LIANG Qiaomi. Determination and quantitation of blood human papillomavirus DNA in healthy subjects [J]. Laboratory Medicine, 2021, 36(11): 1121-1124.
[7]	ZHANG Yunli, WANG Xin, SHAO Ling, QU Bo, ZHAO Hongmei. Comparison of different nucleic acid extraction methods for the detection of SARS-Cov-2 [J]. Laboratory Medicine, 2021, 36(5): 530-534.
[8]	XUAN Binbin, TAN Meiyu, SUN Hanxiao, SHENG Huiming. Mixed infection status of human papillomavirus,Ureaplasma urealyticum,Chlamydia trachomatis and Neisseria gonorrhoeae in Changning district of Shanghai [J]. Laboratory Medicine, 2020, 35(9): 859-863.
[9]	YAN Jianghong, JA Li, LI Wenhui, YANG Shuo, YAN Xiaotong, ZHAO Mengchuan, GUO Weiwei, LIU Yingye, LIU Zehao, WANG Le. Epidemiological characteristics of EB virus infection in inpatients from Hebei Children's Hospital [J]. Laboratory Medicine, 2020, 35(4): 323-326.
[10]	SHEN Qionghua. Role of HPV DNA typing in the differential diagnosis of cervical lesions and cervical cancer [J]. Laboratory Medicine, 2019, 34(6): 498-501.
[11]	ZHANG Baohua, YU Guixiang, JIANG Yan, PAN Hong, JIANG Xiangning. Performance evaluation of GN13 and NM38 to determine the drug susceptibility of carbapenems against Klebsiella pneumoniae [J]. Laboratory Medicine, 2019, 34(3): 263-266.
[12]	. [J]. Laboratory Medicine, 2019, 34(1): 82-83.
[13]	WEI Shanqiu. Research progress on immune factors related with HIV infectious disease development [J]. Laboratory Medicine, 2015, 30(6): 646-649.
[14]	YAO Rongfeng,ZHAO Xuhong,LI Zhi,XUE Long,XU Guoxiang. Analysis on the infection status of human papilloma virus in women with different ages [J]. , 2014, 29(7): 708-711.
[15]	WU Beiying, CAI Gang, LIN Jiafei, FAN Zhenjia, FAN Qishi.. Clinical significance of monitoring BK virus in transplanting patients [J]. , 2014, 29(5): 493-498.